Terri Moench, RPh, MS, is the president of WCG’s Research Solutions. Terri joined WCG in 2019 as general manager of MedAvante-ProPhase and served as president of Patient Engagement, overseeing WCG’s MedAvante-ProPhase, Analgesic Solutions, and ThreeWire. Prior to WCG, she served in multiple leadership roles with GE Healthcare.
Terri is an innovative, forward-thinking professional with extensive experience in the specialty pharmaceutical arena. She has held global roles as a business segment leader and product leader as well as U.S. roles in positions such as Service Business Leader, Commercial Operations, Sales, Marketing and Pharmacy Management. She has a proven track record of success in guiding organizations to achieve optimal profit through swiftly changing technical and business conditions.
Terri is a Pharmacist with a Master of Science in Nuclear Pharmacy.